Denali Therapeutics Inc (DNLI)

Working Capital Ratio

57.33%

Quarterly · Period ending:

DNLI logo

DNLI Working Capital Ratio

Latest reported57.33%
DNLI Quarterly Working Capital Ratio (63.77% → 57.33%)
High-resolution chart · PNG

DNLI working capital ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Denali Therapeutics Inc Working Capital Ratio — Quarterly
Period endingWorking Capital Ratio
57.329%
72.0837%
70.0794%
75.0697%
72.3392%
61.8842%
55.4678%
53.7647%
56.8262%
56.353%
85.4615%
86.653%
88.4334%
66.2778%
69.0568%
63.3637%
59.3008%
48.9982%
36.9608%
69.0539%
85.463%
88.9624%
88.7598%
80.8603%
77.3855%
80.0658%
69.5346%
74.2468%
70.4876%
67.4389%
67.6829%
64.6101%
60.5554%
58.6779%
81.2463%
84.6797%
77.1596%
63.7662%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.